Sentiment Trading

Chengdu Kanghua Biological Products Co Ltd has undergone a strategic shift in ownership, with Shanghai Wanke Xin Biotechnology investing 18.51 billion CNY in the company, marking a significant milestone for the Chinese biotechnology firm.

Chengdu Kanghua Biological Products Co Ltd, a biotech company listed on the Shenzhen Stock Exchange, is undergoing a major corporate shake-up as its major shareholder plans to divest controlling interest.